Logicbio therapeutics, inc. (LOGC)
Income statement / Yearly
Dec'19Dec'18Dec'17
OPERATING EXPENSES
Research and development

30,656

11,079

3,558

General and administrative

10,385

6,864

2,296

Total operating expenses

41,041

17,943

5,854

LOSS FROM OPERATIONS

-41,041

-17,943

-5,854

OTHER INCOME (EXPENSE), NET:
Interest income

1,500

569

54

Interest expense

546

2

-

Other expense, net

-19

-159

67

Total other income (expense), net

935

408

121

Loss before income taxes

-40,106

-17,535

-5,733

Income tax provision

22

86

62

Net loss

-40,128

-17,621

-5,795

Net loss attributable to common stockholders—basic and diluted (Note 10)

-

-

-7,735

Net loss per share—basic and diluted

-1.78

-3.04

-5.54

Weighted-average common stock outstanding—basic and diluted

22,602

5,801

1,395